Merit Medical (NSDQ:MMSI) announced last week that it has been granted FDA breakthrough device designation for its Wrapsody endovascular stent graft system. Wrapsody is a flexible, self-expanding endoprosthesis designed for hemodialysis patients. Merit said it will seek indication to treat stenosis within the central veins of the outflow circuit of an arteriovenous fistula (AVF) up […]
Merit Medical closes $50m BrightWater buyout
BrightWater Medical said today that it completed the sale of the organization to Merit Medical (NSDQ:MMSI), three months after Merit made its $50 million offer. In June, Merit valued the acquisition at $35 million upfront with a further $15 million in potential payments contingent upon CE Mark approval and meeting future sales targets. Temecula, Calif.-based BrightWater’s […]
Merit Medical plunges on Q2 miss, lowered outlook
Merit Medical (NSDQ:MMSI) shares lost more than a quarter of their value today after the medical device maker missed the consensus for its second-quarter sales and earnings and lowered its outlook on the rest of the year. South Jordan, Utah-based Merit posted profits of $6.9 million, or 12¢ per share, on sales of $255.5 million for […]
Merit puts $50m on the table for Brightwater
Merit Medical (NSDQ:MMSI) said this week that it plans to acquire Brightwater Medical in a deal valued at $50 million. Temecula, Calif.-based Brightwater Medical’s lead product, ConvertX, is a device designed to treat severe obstructions of the ureter. The company recently won FDA clearance for its ConvertX biliary stent system, according to Merit Medical. The deal […]
Merit Medical’s Q1 beats push shares higher
A first-quarter sales-and-earnings beat pushed Merit Medical (NSDQ:MMSI) shares up today before the market opened, as the medical device maker maintained its outlook for 2019. South Jordan, Utah-based Merit reported profits of $6.2 million, or 11¢ per share, on sales of $238.3 million for the three months ended March 31, for a 10.0% profit gain on […]
Merit Medical’s Q4, 2018 top The Street
Merit Medical (NSDQ:MMSI) yesterday posted fourth-quarter and full-year sales and earnings that beat the consensus forecast on Wall Street. The South Jordan, Utah-based medical device company reported profits of $9.2 million, or 16¢ per share, on sales of $233.2 million for the three months ended Dec. 31, 2018, representing bottom-line growth of 35.0% on sales growth […]
Merit Medical puts $60m on the table for Vascular Insights
UPDATED May 1, 2019, with milestone terms. Merit Medical (NSDQ:MMSI) said yesterday that it put $60 million on the table to acquire Vascular Insights and its ClariVein line of catheters, including a $20 million milestone pegged to sales targets. Quincy, Mass.-based Vascular Insights makes the ClariVeinIC and ClariVeinOC infusion and occlusion catheters for treating superficial […]
Merit Medical wins FDA nod for EmboCube embolization gelatin
Merit Medical received FDA 510(k) clearance for its EmboCube embolization gelatin. EmboCube is used in the embolization of hypervascular tumors. It features uniformly cut cubes of gelatin foam that have been designed to address preparation concerns and inconsistent particle sizes that come with traditional gelatin foam sheets as an embolic. Embocube gets preloaded into a Medallion […]
Merit Medical closes $200m Cianna Medical buy
Merit Medical (NSDQ:MMSI) said yesterday that it closed its $200 million acquisition of Cianna Medical, making the company a wholly-owned subsidiary. Aliso Viejo, Calif.-based Cianna makes the Savi Scout wire-free breast tumor localization system, designed to produce audible and visual indicators surgeons can use to tag cancerous tissue during lumpectomy and biopsy procedures. The device won 510(k) clearance from […]
FDA clears NinePoint Medical’s AI-powered IRIS upgrade for Nvision VLE esophageal imager
NinePoint Medical said today that it won FDA 510(k) clearance for the Intelligent Real-time Image Segmentation software upgrade for its flagship Nvision VLE imaging system. The newly cleared IRIS is an artificial intelligence-based platform for image feature segmentation, the Bedford, Mass.-based company said. The company touted that the approval was the first of its kind for […]
Merit Medical logs Q3 sales and earnings beat
Merit Medical (NSDQ:MMSI) yesterday put up third-quarter numbers that beat expectations on both sales and earnings and confirmed that it’s on track to hit the midpoint of its guidance for the rest of the year. South Jordan, Utah-based Merit posted a swing to black ink for the three months ended Sept. 30, with profits of $16.6 […]
- 1
- 2
- 3
- …
- 7
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube